Wealthspire Advisors (New York)’s Ambev ABEV Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,067	Closed	-$84.1K	–	935
2025 Q4	$84.1K	Buy	+34,067	New	+$81.1K	﹤0.01%	1004
2021 Q2	–	Sell	-11,217	Closed	-$31K	–	369
2021 Q1	$31K	Buy	11,217 +257	+2%	+$726	﹤0.01%	701
2020 Q4	$34K	Buy	+10,960	New	+$29.6K	﹤0.01%	577
2020 Q2	–	Sell	-13,911	Closed	-$32K	–	283
2020 Q1	$32K	Buy	+13,911	New	+$50.3K	﹤0.01%	549
2019 Q1	–	Sell	-867	Closed	-$3K	–	51
2018 Q4	$3K	Buy	+867	New	+$3.7K	﹤0.01%	701

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealthspire Advisors (New York)'s ABEV Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Ambev (ABEV) in Q1 2026, closing a stake of 34,067 shares — an estimated $84.1K sold.

Wealthspire Advisors (New York) first reported a position in ABEV in Q4 2018 and held it in 5 quarters. The position peaked at $84.1K in Q4 2025. 404 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

Wealthspire Advisors (New York) reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
Wealthspire Advisors (New York) sold 34,067 Ambev shares in Q1 2026, an estimated $84.1K.
Wealthspire Advisors (New York) first reported a position in Ambev in Q4 2018 and held it in 5 quarters.
Wealthspire Advisors (New York)'s Ambev position peaked at $84.1K in Q4 2025.
404 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.